Dr. Lal PathLabs has announced the completion of Mr. Gurinder Singh Kalra’s tenure as an Independent Director. His term concluded on July 26, 2026, at the close of business hours. This marks the end of his service as an independent director for the company. Further details regarding the change are provided in Annexure-A, as per regulatory requirements.
Announcement of Director’s Tenure Completion
Dr. Lal PathLabs Limited has formally notified the stock exchanges regarding the conclusion of Mr. Gurinder Singh Kalra’s service as an Independent Director. His tenure officially ended on July 26, 2026, at the closing business hours.
Regulatory Compliance and Details
This intimation is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Kalra, holding DIN 10197218, ceased to be an Independent Director from July 26, 2026. The detailed information required under the listing regulations, including the reason for the change and the date of cessation, is attached as Annexure-A.
Annexure-A Summary
Annexure-A confirms that Mr. Gurinder Singh Kalra’s cessation as an Independent Director is due to the completion of his tenure. His date of cessation is noted as July 26, 2026 (closing business hours). The annexure also states ‘Not Applicable’ for the brief profile and disclosure of relationships, as these are typically required upon appointment rather than cessation.
Source: BSE
